<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmcsurg&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Surgery - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmcsurg/</link>
        <description>The latest research articles published by BMC Surgery</description>
        <dc:date>2009-10-24T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2482/9/16" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2482/9/15" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2482/9/14" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2482/9/13" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2482/9/12" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2482/9/11" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2482/9/10" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2482/9/9" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2482/9/8" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2482/9/7" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2482/9/16">
        <title>Internal sphincterotomy reduces postoperative pain after Milligan Morgan haemorrhoidectomy.</title>
        <description>Background:
Over the last few years, there has been increasing attention on surgical procedures to treat haemorrhoids. The Milligan-Morgan haemorrhoidectomy is still one of the most popular surgical treatments of haemorrhoids. The aim of the present work is to assess postoperative pain, together with other early and late complications, after Milligan-Morgan haemorrhoidectomy as we could observe in our experience before and after performing an internal sphincterotomy.
Methods:
from January 1980 to May 2007, we operated 850 patients, but only 699 patients (median age 53) were included in the present study because they satisfied our inclusion criteria. The patients were divided into two groups: all the patients operated on before 1995 (group A); all the patients operated on after 1995 (group B). Since 1995 an internal sphincterotomy of about 1 cm has been performed at the end of the procedure. The data concerning the complications of these two groups were compared. All the patients received a check-up at one and six months after operation and a telephone questionnaire three years after operation to evalue medium and long term results.
Results:
after one month 507 patients (72.5%) did not have any postoperative complication. Only 192 patients (27.46%) out of 699 presented postoperative complication and the most frequent one (23.03%) was pain. The number of patients who suffered from postoperative pain decreased significantly when performing internal sphincterotomy, going from 28.8% down to 10.45% (&#967;2: 10,880; p = 0,0001); 95% Confidence Interval (CI) 24.7 to 28.9 (group A) and 10.17 to 10.72 (group B). In 51 cases (7.29%) urinary retention was registered. Six cases of bleeding (0.85%) were registered. Medium and long term follow up did not show any difference among the two groups.
Conclusion:
internal sphincterotomy: reduces significantly pain only in the first postoperative period, but not in the medium-long term follow up; does not increase the incidence of continence impairment when performed; does not influence the incidence of the other postoperative complications especially as regard medium and long term results.</description>
        <link>http://www.biomedcentral.com/1471-2482/9/16</link>
                <dc:creator>Giuseppe Diana</dc:creator>
                <dc:creator>Giovanni Guercio</dc:creator>
                <dc:creator>Bianca Cudia</dc:creator>
                <dc:creator>Calogero Ricotta</dc:creator>
                <dc:source>BMC Surgery 2009, 9:16</dc:source>
        <dc:date>2009-10-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2482-9-16</dc:identifier>
        <prism:publicationName>BMC Surgery</prism:publicationName>
        <prism:issn>1471-2482</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>16</prism:startingPage>
        <prism:publicationDate>2009-10-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2482/9/15">
        <title>Evolution of breast cancer management in Ireland: a decade of change</title>
        <description>Background:
Over the last decade there has been a paradigm shift in the management of breast cancer, subsequent to revised surgical oncology guidelines and consensus statements which were derived in light of landmark breast cancer clinical trials conducted throughout the latter part of the 20th century. However the sheer impact of this paradigm shift upon all modalities of treatment, and the current trends in management of the disease, are largely unknown. We aimed to assess the changing practices of breast cancer management over the last decade within a specialist tertiary referral Breast Cancer Centre.
Methods:
Comparative analysis of all aspects of the management of breast cancer patients, who presented to a tertiary referral Breast Cancer Centre in 1995/1996 and 2005/2006, was undertaken and measured against The European Society for Surgical Oncology guidelines for the surgical management of mammographically detected lesions [1998].
Results:
613 patients&apos; case profiles were analysed. Over the last decade we observed a dramatic increase in incidence of breast cancer [&gt;100%], a move to less invasive diagnostic and surgical therapeutic techniques, as well as increased use of adjuvant therapies. We also witnessed the introduction of immediate breast reconstruction as part of routine practice
Conclusion:
We demonstrate that radical changes have occurred in the management of breast cancer in the last decade, in keeping with international guidelines. It remains incumbent upon us to continue to adapt our practice patterns in light of emerging knowledge and best evidence.</description>
        <link>http://www.biomedcentral.com/1471-2482/9/15</link>
                <dc:creator>Helen Heneghan</dc:creator>
                <dc:creator>Ruth Prichard</dc:creator>
                <dc:creator>Amanda Devaney</dc:creator>
                <dc:creator>Karl Sweeney</dc:creator>
                <dc:creator>Carmel Malone</dc:creator>
                <dc:creator>Ray McLaughlin</dc:creator>
                <dc:creator>Michael Kerin</dc:creator>
                <dc:source>BMC Surgery 2009, 9:15</dc:source>
        <dc:date>2009-09-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2482-9-15</dc:identifier>
        <prism:publicationName>BMC Surgery</prism:publicationName>
        <prism:issn>1471-2482</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>15</prism:startingPage>
        <prism:publicationDate>2009-09-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2482/9/14">
        <title>Laparoscopic versus open left lateral segmentectomy </title>
        <description>Background:
Laparoscopic liver surgery is becoming increasingly common. This cohort study was designed to directly compare perioperative outcomes of the left lateral segmentectomy via laparoscopic and open approach.
Methods:
Between 2002 and 2006 43 left lateral segmentectomies were performed at King&apos;s College Hospital. Those excluded from analysis included previous liver resections, polycystic liver disease, liver cirrhosis and synchronous operations. Of 20 patients analysed, laparoscopic (n = 10) were compared with open left lateral segmentectomy (n = 10). Both groups had similar patient characteristics.
Results:
Morbidity rates were similar with no wound or chest infection in either group. The conversion rate was 10% (1/10). There was no difference in operating time between the groups (median time 220 minutes versus 179 minutes, p = 0.315). Surgical margins for all lesions were clear. Less postoperative opiate analgesics were required in the laparoscopic group (median 2 days versus 5 days, p = 0.005). The median postoperative in-hospital stay was less in the laparoscopic group (6 days vs 9 days, p = 0.005). There was no mortality.
Conclusion:
Laparoscopic left lateral segmentectomy is safe and feasible. Laparoscopic patients may benefit from requiring less postoperative opiate analgesia and a shorter post-operative in-hospital stay.</description>
        <link>http://www.biomedcentral.com/1471-2482/9/14</link>
                <dc:creator>Kirstin Carswell</dc:creator>
                <dc:creator>Filippos Sagias</dc:creator>
                <dc:creator>Beth Murgatroyd</dc:creator>
                <dc:creator>Mohamed Rela</dc:creator>
                <dc:creator>Nigel Heaton</dc:creator>
                <dc:creator>Ameet Patel</dc:creator>
                <dc:source>BMC Surgery 2009, 9:14</dc:source>
        <dc:date>2009-09-07T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2482-9-14</dc:identifier>
        <prism:publicationName>BMC Surgery</prism:publicationName>
        <prism:issn>1471-2482</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>14</prism:startingPage>
        <prism:publicationDate>2009-09-07T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2482/9/13">
        <title>Prediction of conversion of laparoscopic cholecystectomy to open surgery with artificial neural networks  </title>
        <description>Background:
The intent of this study was to predict conversion of laparoscopic cholecystectomy (LC) to open surgery employing artificial neural networks (ANN).
Methods:
The retrospective data of 793 patients who underwent LC in a teaching university hospital from 1997 to 2004 was collected. We employed linear discrimination analysis and ANN models to examine the predictability of the conversion. The models were validated using prospective data of 100 patients who underwent LC at the same hospital.
Results:
The overall conversion rate was 9%. Conversion correlated with experience of surgeons, emergency LC, previous abdominal surgery, fever, leukocytosis, elevated bilirubin and alkaline phosphatase levels, and ultrasonographic detection of common bile duct stones. In the validation group, discriminant analysis formula diagnosed the conversion in 5 cases out of 9 (sensitivity: 56%; specificity: 82%); the ANN model diagnosed 6 cases (sensitivity: 67%; specificity: 99%).
Conclusion:
The conversion of LC to open surgery is effectively predictable based on the preoperative health characteristics of patients using ANN.</description>
        <link>http://www.biomedcentral.com/1471-2482/9/13</link>
                <dc:creator>Changiz Gholipour</dc:creator>
                <dc:creator>Mohammad  Bassir Abolghasemi Fakhree</dc:creator>
                <dc:creator>Rosita Alizadeh Shalchi</dc:creator>
                <dc:creator>Mehrshad Abbasi</dc:creator>
                <dc:source>BMC Surgery 2009, 9:13</dc:source>
        <dc:date>2009-08-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2482-9-13</dc:identifier>
        <prism:publicationName>BMC Surgery</prism:publicationName>
        <prism:issn>1471-2482</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>13</prism:startingPage>
        <prism:publicationDate>2009-08-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2482/9/12">
        <title>Development of a clinical decision model for thyroid nodules</title>
        <description>Background:
Thyroid nodules represent a common problem brought to medical attention. Four to seven percent of the United States adult population (10&#8211;18 million people) has a palpable thyroid nodule, however the majority (&gt;95%) of thyroid nodules are benign. While, fine needle aspiration remains the most cost effective and accurate diagnostic tool for thyroid nodules in current practice, over 20% of patients undergoing FNA of a thyroid nodule have indeterminate cytology (follicular neoplasm) with associated malignancy risk prevalence of 20&#8211;30%. These patients require thyroid lobectomy/isthmusectomy purely for the purpose of attaining a definitive diagnosis. Given that the majority (70&#8211;80%) of these patients have benign surgical pathology, thyroidectomy in these patients is conducted principally with diagnostic intent. Clinical models predictive of malignancy risk are needed to support treatment decisions in patients with thyroid nodules in order to reduce morbidity associated with unnecessary diagnostic surgery.
Methods:
Data were analyzed from a completed prospective cohort trial conducted over a 4-year period involving 216 patients with thyroid nodules undergoing ultrasound (US), electrical impedance scanning (EIS) and fine needle aspiration cytology (FNA) prior to thyroidectomy. A Bayesian model was designed to predict malignancy in thyroid nodules based on multivariate dependence relationships between independent covariates. Ten-fold cross-validation was performed to estimate classifier error wherein the data set was randomized into ten separate and unique train and test sets consisting of a training set (90% of records) and a test set (10% of records). A receiver-operating-characteristics (ROC) curve of these predictions and area under the curve (AUC) were calculated to determine model robustness for predicting malignancy in thyroid nodules.
Results:
Thyroid nodule size, FNA cytology, US and EIS characteristics were highly predictive of malignancy. Cross validation of the model created with Bayesian Network Analysis effectively predicted malignancy [AUC = 0.88 (95%CI: 0.82&#8211;0.94)] in thyroid nodules. The positive and negative predictive values of the model are 83% (95%CI: 76%&#8211;91%) and 79% (95%CI: 72%&#8211;86%), respectively.
Conclusion:
An integrated predictive decision model using Bayesian inference incorporating readily obtainable thyroid nodule measures is clinically relevant, as it effectively predicts malignancy in thyroid nodules. This model warrants further validation testing in prospective clinical trials.</description>
        <link>http://www.biomedcentral.com/1471-2482/9/12</link>
                <dc:creator>Alexander Stojadinovic</dc:creator>
                <dc:creator>George Peoples</dc:creator>
                <dc:creator>Steven Libutti</dc:creator>
                <dc:creator>Leonard Henry</dc:creator>
                <dc:creator>John Eberhardt</dc:creator>
                <dc:creator>Robin Howard</dc:creator>
                <dc:creator>David Gur</dc:creator>
                <dc:creator>Eric Elster</dc:creator>
                <dc:creator>Aviram Nissan</dc:creator>
                <dc:source>BMC Surgery 2009, 9:12</dc:source>
        <dc:date>2009-08-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2482-9-12</dc:identifier>
        <prism:publicationName>BMC Surgery</prism:publicationName>
        <prism:issn>1471-2482</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2009-08-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2482/9/11">
        <title>APACHE III outcome prediction in patients admitted to the intensive care unit after liver transplantation: a retrospective cohort study</title>
        <description>Background:
The Acute Physiology and Chronic Health Evaluation (APACHE) III prognostic system has not been previously validated in patients admitted to the intensive care unit (ICU) after orthotopic liver transplantation (OLT). We hypothesized that APACHE III would perform satisfactorily in patients after OLT
Methods:
A retrospective cohort study was performed. Patients admitted to the ICU after OLT between July 1996 and May 2008 were identified. Data were abstracted from the institutional APACHE III and liver transplantation databases and individual patient medical records. Standardized mortality ratios (with 95% confidence intervals) were calculated by dividing the observed mortality rates by the rates predicted by APACHE III. The area under the receiver operating characteristic curve (AUC) and the Hosmer-Lemeshow C statistic were used to assess, respectively, discrimination and calibration of APACHE III.
Results:
APACHE III data were available for 918 admissions after OLT. Mean (standard deviation [SD]) APACHE III (APIII) and Acute Physiology (APS) scores on the day of transplant were 60.5 (25.8) and 50.8 (23.6), respectively. Mean (SD) predicted ICU and hospital mortality rates were 7.3% (15.4) and 10.6% (18.9), respectively. The observed ICU and hospital mortality rates were 1.1% and 3.4%, respectively. The standardized ICU and hospital mortality ratios with their 95% C.I. were 0.15 (0.07 to 0.27) and 0.32 (0.22 to 0.45), respectively.There were statistically significant differences in APS, APIII, predicted ICU and predicted hospital mortality between survivors and non-survivors. In predicting mortality, the AUC of APACHE III prediction of hospital death was 0.65 (95% CI, 0.62 to 0.68). The Hosmer-Lemeshow C statistic was 5.288 with a p value of 0.871 (10 degrees of freedom).
Conclusion:
APACHE III discriminates poorly between survivors and non-survivors of patients admitted to the ICU after OLT. Though APACHE III has been shown to be valid in heterogenous populations and in certain groups of patients with specific diagnoses, it should be used with caution &#8211; if used at all &#8211; in recipients of liver transplantation.</description>
        <link>http://www.biomedcentral.com/1471-2482/9/11</link>
                <dc:creator>Mark Keegan</dc:creator>
                <dc:creator>Bhargavi Gali</dc:creator>
                <dc:creator>James Findlay</dc:creator>
                <dc:creator>Julie Heimbach</dc:creator>
                <dc:creator>David Plevak</dc:creator>
                <dc:creator>Bekele Afessa</dc:creator>
                <dc:source>BMC Surgery 2009, 9:11</dc:source>
        <dc:date>2009-07-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2482-9-11</dc:identifier>
        <prism:publicationName>BMC Surgery</prism:publicationName>
        <prism:issn>1471-2482</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2009-07-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2482/9/10">
        <title>Radical Prostatectomy: Hospital volumes and surgical volumes - does practice make perfect?  </title>
        <description>Background:
Between the years 1993 and 2003, more than 140,000 men underwent radical prostatectomy (RP), thus making RP one of the most common treatment options for localized prostate cancer in the United States.DiscussionLocalized prostate cancer treated by RP is one of the more challenging procedures performed by urologic surgeons. Studies suggest a definite learning curve in performing this procedure with optimal results noted after performing &gt;500 RPs. But is surgical volume everything? How do hospital volumes of RP weigh in? Could fellowship training in RP reduce the critical volume needed to reach an &apos;experienced&apos; level?SummaryAs we continue to glean data as to how to optimize outcomes after RP, we must not only consider surgeon and hospital volumes of RP, but also consider training of the individual surgeon.</description>
        <link>http://www.biomedcentral.com/1471-2482/9/10</link>
                <dc:creator>Cydney Urbanek</dc:creator>
                <dc:creator>Ryan Turpen</dc:creator>
                <dc:creator>Charles Rosser</dc:creator>
                <dc:source>BMC Surgery 2009, 9:10</dc:source>
        <dc:date>2009-06-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2482-9-10</dc:identifier>
        <prism:publicationName>BMC Surgery</prism:publicationName>
        <prism:issn>1471-2482</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2009-06-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2482/9/9">
        <title> Diagnostic problems with parasitic and non-parasitic splenic cysts</title>
        <description>Background:
The splenic cysts constitute a very rare clinical entity. They may occur secondary to trauma or even being more seldom due to parasitic infestations, mainly caused by ecchinocccus granulosus. Literature lacks a defined concencus including the treatment plans and follow up strategies, nor long term results of the patients. In the current study, we aimed to evaluate the diagnosis, management of patients with parasitic and non-parasitic splenic cysts together with their long term follow up progresses.
Methods:
Twenty-four patients with splenic cysts have undergone surgery in our department over the last 9 years. Data from eighteen of the twenty-four patients were collected prospectively, while data from six were retrospectively collected. All patients were assessed in terms of age, gender, hospital stay, preoperative diagnosis, additional disease, serology, ultrasonography, computed tomography (CT), cyst recurrences and treatment.
Results:
In this study, the majority of patients presented with abdominal discomfort and palpable swelling in the left hypochondrium. All patients were operated on electively. The patients included 14 female and 10 male patients, with a mean age of 44.77 years (range 20&#8211;62). Splenic hydatid cysts were present in 16 patients, one of whom also had liver hydatid cysts (6.25%). Four other patients were operated on for a simple cyst (16%) two patients for an epithelial cyst, and the last two for splenic lymphangioma. Of the 16 patients diagnosed as having splenic hydatit cysts, 11 (68.7%) were correctly diagnosed. Only two of these patients were administered benzimidazole therapy pre-operatively because of the risk of multicystic disease The mean follow-up period was 64 months (6&#8211;108). There were no recurrences of splenic cysts.
Conclusion:
Surgeons should keep in mind the possibility of a parasitic cyst when no definitive alternative diagnosis can be made. In the treatment of splenic hydatidosis, benzimidazole therapy is not necessary, although it is crucial to perform splenectomy without rupturing and spilling the cysts.</description>
        <link>http://www.biomedcentral.com/1471-2482/9/9</link>
                <dc:creator>Gokhan Adas</dc:creator>
                <dc:creator>Oguzhan Karatepe</dc:creator>
                <dc:creator>Merih Altiok</dc:creator>
                <dc:creator>Muharrem Battal</dc:creator>
                <dc:creator>Omer Bender</dc:creator>
                <dc:creator>Deniz Ozcan</dc:creator>
                <dc:creator>Servet Karahan</dc:creator>
                <dc:source>BMC Surgery 2009, 9:9</dc:source>
        <dc:date>2009-05-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2482-9-9</dc:identifier>
        <prism:publicationName>BMC Surgery</prism:publicationName>
        <prism:issn>1471-2482</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2009-05-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2482/9/8">
        <title>Current practice of abdominal wall closure in elective surgery - Is there any consensus?</title>
        <description>Background:
Development of incisional hernia after open abdominal surgery remains a major cause of post-operative morbidity. The aim of this study was to determine the current practice of surgeons in terms of access to and closure of the abdominal cavity in elective open surgery.
Methods:
Twelve surgical departments of the INSECT-Trial group documented the following variables for 50 consecutive patients undergoing abdominal surgery: fascial closure techniques, applied suture materials, application of subcutaneous sutures, subcutaneous drains, methods for skin closure. Descriptive analysis was performed and consensus of treatment variables was categorized into four levels: Strong consensus &gt;95%, consensus 75&#8211;95%, overall agreement 50&#8211;75%, no consensus &lt;50%.
Results:
157 out of 599 patients were eligible for analysis (85 (54%) midline, 54 (35%) transverse incisions). After midline incisions the fascia was closed continuously in 55 patients (65%), using slowly absorbable (n = 47, 55%), braided (n = 32, 38%) sutures with a strength of 1 (n = 48, 57%). In the transverse setting the fascia was closed continuously in 39 patients (72%) with slowly absorbable (n = 22, 41%) braided sutures (n = 27, 50%) with a strength of 1 (n = 30, 56%).
Conclusion:
In the present evaluation midline incision was the most frequently applied access in elective open abdominal surgery. None of the treatments for abdominal wall closure (except skin closure in the midline group) is performed on a consensus level.</description>
        <link>http://www.biomedcentral.com/1471-2482/9/8</link>
                <dc:creator>Nuh Rahbari</dc:creator>
                <dc:creator>Philip Knebel</dc:creator>
                <dc:creator>Markus Diener</dc:creator>
                <dc:creator>Christoph Seidlmayer</dc:creator>
                <dc:creator>Karsten Ridwelski</dc:creator>
                <dc:creator>Hartmut Stoltzing</dc:creator>
                <dc:creator>Christoph Seiler</dc:creator>
                <dc:source>BMC Surgery 2009, 9:8</dc:source>
        <dc:date>2009-05-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2482-9-8</dc:identifier>
        <prism:publicationName>BMC Surgery</prism:publicationName>
        <prism:issn>1471-2482</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2009-05-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2482/9/7">
        <title>Intraoperative Angiography Should be Standard in Cerebral Aneurysm Surgery</title>
        <description>Intraoperative angiography (IOA) has proven to be a safe and effective adjunct to surgical repair of cerebral aneurysms. Substantial practice variation exists regarding use of this modality in different centers, including use of IOA routinely, selectively, or rarely. In this editorial, we discuss our experience and review the existing literature to develop an argument for routine use of IOA during cerebral aneurysm surgery.</description>
        <link>http://www.biomedcentral.com/1471-2482/9/7</link>
                <dc:creator>Jonathan Friedman</dc:creator>
                <dc:creator>Ravi Kumar</dc:creator>
                <dc:source>BMC Surgery 2009, 9:7</dc:source>
        <dc:date>2009-04-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2482-9-7</dc:identifier>
        <prism:publicationName>BMC Surgery</prism:publicationName>
        <prism:issn>1471-2482</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2009-04-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
